NEW YORK, Aug. 27 - Applied Biosystems and the Institute for Systems Biology today said they will collaborate to develop new proteomic technologies and applications.
The partners said they will use mass spectrometry, chemical tagging, and bioinformatics, including LC MALDI workflows, to devise better ways to analyze proteins in various biological pathways.
Meantime, ISB will use ABI's 4700 proteomics analyzer with ToF/ToF optics and the ICAT reagent technology to help it study human immunity.
ISB researchers in Seattle and teams from ABI's proteomics research center in Framingham, Mass., will perform the research.
Click here for more information.